Depression is characterised by persistent low mood or sadness, and impairments of a range of other bodily functions such as sleep, appetite, concentration and memory and the ability to enjoy normally pleasurable acitities.
Safety of antidepressants in children
Note: some of these documents require Adobe Acrobat Reader which is free and available from Adobe (click here)
Safety messages from the Medicines and Healthcare products Regulatory Agency:
Selective Serotonin Reuptake Inhibitors (SSRIs): Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data
Report of the CSM Expert Working Group on the safety of Selective Serotonin Reuptake Inhibitor antidepressants
Other sources of information:
Depression in children and young people: NICE (National Institute for Health and Clinical Excellence) guideline
